Estrone Analysis Products Radioimmunoassay Estrone

FDA 510(k) K864966 · Diagnostics Biochem Canada, Inc.

Substantially Equivalent

510(k) numberK864966

Submission

Device name
Estrone Analysis Products Radioimmunoassay Estrone
Applicant
Diagnostics Biochem Canada, Inc.
London, Ontario, CA
Received
December 22, 1986
Decision date
January 9, 1987
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
CGF – Radioimmunoassay, Estrone
Device class
Class I (low risk)
Regulation
21 CFR 862.1280
Specialty
Clinical Chemistry

Other 510(k)s with product code CGF

510(k)DeviceApplicantDecision
K970915DSL Estrone-Sulfate RiaCGF · Traditional Diagnostic Systems Laboratories, Inc.05/16/1997SE
K935013DSL Estrone (DSL 8700)CGF · Traditional Diagnostic Systems Laboratories, Inc.06/16/1994SE
K833406Immophase D-Te 3 RadioimmunoassayCGF · Traditional Corning Medical & Scientific01/24/1984SE

More from Corning Medical & Scientific

510(k)DeviceDecision
K030730Free Testosterone Enzymeimmunoassay (Eia) KitCDZ · Traditional 08/18/2003SE
K014120Testosterone by Enzymeimmunoassay (Eia)CDZ · Traditional 02/08/2002SE
K832297HYDROXYPROGESTERONE-17JLS · Traditional 09/01/1983SE
K801729Androstenedione Radioimmunoassay KitCIZ · Traditional 10/31/1980SE
K781310Human Chorionic Gonado.-Beta Ria KitJHI · Traditional 08/31/1978SE

Questions and answers

When was Estrone Analysis Products Radioimmunoassay Estrone cleared by the FDA?

Estrone Analysis Products Radioimmunoassay Estrone (K864966) received a 510(k) decision of Substantially Equivalent on January 9, 1987, 18 days after the submission was received.

What is the product code of K864966?

The FDA product code is CGF – Radioimmunoassay, Estrone, a Class I (low risk) device regulated under 21 CFR 862.1280.